// App-Quantinova.ai

880 : Tofacitinib Treatment in Patients with Psoriatic Arthritis and Rates of Radiologic Progression According to Baseline CRP Levels: Results from a Phase 3 Clinical Study

Researchers

Presenter

  • Dsire van der Heijde

Principal Investigators

  • Dafna D Gladman

  • Oliver Fitz Gerald

  • Arthur Kavanaugh

  • Daniela Graham

  • Cunshan Wang

  • Lara Fallon

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Department of Medical Imaging, University of Toronto, Toronto General Hospital, Toronto, ON, Canada

  • Department of Endocrinology, St Vincents University Hospital, Dublin 4, Ireland

  • University of California, San Diego School of Medicine, La Jolla, CA

  • Pfizer, Groton, CT

  • Pfizer Canada, Montreal, QC, Canada

Locations

  • Netherlands

  • Canada

  • Ireland

  • United States

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Janus kinase

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • Placebo Control

  • Controlled

  • Parallel Group

Phase

  • III

Study Id's

  • NCT01877668

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved